+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

mRNA Therapeutics and Vaccines: Key Opinion Leaders - Product Thumbnail Image

mRNA Therapeutics and Vaccines: Key Opinion Leaders

  • Report
  • September 2021
  • 116 Pages
  • Global
From
From
From
Global Dravet Syndrome Treatment Market 2023-2027 - Product Thumbnail Image

Global Dravet Syndrome Treatment Market 2023-2027

  • Report
  • December 2022
  • 163 Pages
  • Global
From
Friedreich Ataxia - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 91 Pages
  • Global
From
Becker Muscular Dystrophy - Pipeline Review, H2 2020 - Product Thumbnail Image

Becker Muscular Dystrophy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 95 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Review, H2 2020 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 413 Pages
  • Global
From
From
Huntington's Disease Treatment Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Huntington's Disease Treatment Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 145 Pages
  • Global
From
Friedreich Ataxia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Friedreich Ataxia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 90 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 223 Pages
  • Global
From
From
From
From
From
Loading Indicator